Literature DB >> 4863051

Circulating antibodies in polymyositis.

G M Stern, A L Rose, K Jacobs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4863051     DOI: 10.1016/0022-510x(67)90015-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  8 in total

1.  Inclusion body myositis. A "slow-virus" infection of skeletal musculature?

Authors:  U P Ketelsen; R Beckmann; H Zimmermann; M Sauer
Journal:  Klin Wochenschr       Date:  1977-11-01

2.  Fatal polymyositis: morphogenesis and ultrastructural features.

Authors:  A J Martinez; H Hooshmand; G I Mendoza; Y E Winston
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

3.  Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis.

Authors:  R L Dawkins; A Eghtedari; E J Holborow
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

4.  Antinuclear antibody with distinct specificity for polymyositis.

Authors:  J F Wolfe; E Adelstein; G C Sharp
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

5.  Radioimmunoassay for antibodies to human skeletal muscle myosin in serum from patients with polymyositis.

Authors:  K Wada; S Ueno; T Hazama; S Ogasahara; J Kang; M Takahashi; S Tarui
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

6.  Lymphotoxin formation by lymphocytes and muscle in polymyositis.

Authors:  R L Johnson; C W Fink; M Ziff
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

7.  Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis.

Authors:  J M Goust; A Castaigne; R Moulias
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

8.  Characterization of polymyositis infiltrates using monoclonal antibodies to human leucocyte antigens.

Authors:  D J Rowe; D A Isenberg; J McDougall; P C Beverley
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.